This page compiles research citations referenced throughout Age Well Science. All studies are peer-reviewed and published in scientific journals. Citations include links to PubMed, NIH databases, or journal DOI identifiers where available. This resource is maintained by our research team and updated as new longevity science emerges.
ZOMBIE CELLS
Cellular Senescence & Senolytics
Kirkland JL, Tchkonia T. (2020). "Senolytic drugs: from discovery to translation." Journal of Internal Medicine, 288(5), 518-536.
Reviews the discovery and development of senolytic compounds that selectively eliminate senescent cells, demonstrating their potential to delay age-related physical dysfunction and extend healthspan.
Baker DJ, Wijshake T, Tchkonia T, et al. (2011). "Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders." Nature, 479(7372), 232-236.
Landmark study showing that removing senescent cells in mice delayed the onset of age-related pathologies and extended healthspan, establishing proof-of-concept for senolytic interventions.
Xu M, Pirtskhalava T, Farr JN, et al. (2018). "Senolytics improve physical function and increase lifespan in old age." Nature Medicine, 24(8), 1246-1256.
Demonstrates that senolytic treatment in very old mice improved physical function, reduced frailty, and extended remaining lifespan, with benefits observed even when treatment started late in life.
van Deursen JM. (2014). "The role of senescent cells in ageing." Nature, 509(7501), 439-446.
Comprehensive review explaining how senescent cells accumulate with age and contribute to tissue dysfunction through the senescence-associated secretory phenotype (SASP).
CELLULAR METABOLISM
NAD+ Decline in Aging
Yoshino J, Baur JA, Imai SI. (2018). "NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR." Cell Metabolism, 27(3), 513-528.
Shows NAD+ levels decline ~50% by age 60 and examines how NAD+ precursors (NMN and NR) may restore cellular NAD+ pools to support healthy aging processes.
Rajman L, Chwalek K, Sinclair DA. (2018). "Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence." Cell Metabolism, 27(3), 529-547.
Reviews in vivo evidence showing NAD+ restoration improves muscle function, cognition, cardiovascular health, and metabolic markers in aging animal models.
Verdin E. (2015). "NAD+ in aging, metabolism, and neurodegeneration." Science, 350(6265), 1208-1213.
Comprehensive review linking NAD+ depletion to multiple hallmarks of aging including mitochondrial dysfunction, genomic instability, and stem cell exhaustion.
Mills KF, Yoshida S, Stein LR, et al. (2016). "Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice." Cell Metabolism, 24(6), 795-806.
Demonstrates that long-term NMN supplementation in mice suppressed age-associated body weight gain, enhanced energy metabolism, improved insulin sensitivity, and prevented age-related gene expression changes.
CELLULAR CLEANING
Autophagy & Cellular Quality Control
Rubinsztein DC, Mariño G, Kroemer G. (2011). "Autophagy and aging." Cell, 146(5), 682-695.
Reviews how autophagy declines with age and how this contributes to the accumulation of damaged proteins and organelles, linking impaired autophagy to age-related disease.
Madeo F, Zimmermann A, Maiuri MC, Kroemer G. (2015). "Essential role for autophagy in life span extension." Journal of Clinical Investigation, 125(1), 85-93.
Demonstrates that autophagy induction is a common mechanism underlying multiple longevity interventions including caloric restriction, rapamycin, and spermidine.
Kaushik S, Cuervo AM. (2018). "The coming of age of chaperone-mediated autophagy." Nature Reviews Molecular Cell Biology, 19(6), 365-381.
Reviews chaperone-mediated autophagy, a selective degradation pathway that declines with age and contributes to protein aggregate accumulation in aging cells.
CHROMOSOMAL AGING
Telomeres & Cellular Aging
Blackburn EH, Epel ES, Lin J. (2015). "Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection." Science, 350(6265), 1193-1198.
Comprehensive review showing how telomere length serves as a biomarker of cellular aging and how lifestyle factors including stress, sleep, exercise, and diet influence telomere maintenance.
Ornish D, Lin J, Chan JM, et al. (2013). "Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study." Lancet Oncology, 14(11), 1112-1120.
Demonstrates that comprehensive lifestyle changes including diet, exercise, stress management, and social support were associated with increased telomerase activity and telomere length over 5 years.
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. (2013). "The hallmarks of aging." Cell, 153(6), 1194-1217.
Landmark review identifying telomere attrition as one of the nine hallmarks of aging, along with genomic instability, epigenetic alterations, and mitochondrial dysfunction.
CELLULAR POWERHOUSES
Mitochondrial Dysfunction in Aging
Sun N, Youle RJ, Finkel T. (2016). "The Mitochondrial Basis of Aging." Molecular Cell, 61(5), 654-666.
Reviews how mitochondrial dysfunction accumulates with age through mtDNA mutations, impaired mitophagy, and altered mitochondrial dynamics, contributing to cellular senescence and tissue aging.
Palikaras K, Lionaki E, Tavernarakis N. (2018). "Mechanisms of mitophagy in cellular homeostasis, physiology and pathology." Nature Cell Biology, 20(9), 1013-1022.
Examines mitophagy, the selective removal of damaged mitochondria, and how its decline with age contributes to accumulation of dysfunctional mitochondria and metabolic disease.
Marzetti E, Calvani R, Cesari M, et al. (2013). "Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials." International Journal of Biochemistry & Cell Biology, 45(10), 2288-2301.
Links age-related mitochondrial dysfunction to sarcopenia (muscle loss), demonstrating how impaired mitochondrial quality control contributes to loss of muscle mass and function.
BIOLOGICAL AGE
Epigenetic Clocks & DNA Methylation
Horvath S, Raj K. (2018). "DNA methylation-based biomarkers and the epigenetic clock theory of ageing." Nature Reviews Genetics, 19(6), 371-384.
Reviews epigenetic clocks that measure biological age through DNA methylation patterns, showing how biological age can differ from chronological age and predict mortality risk.
Levine ME, Lu AT, Quach A, et al. (2018). "An epigenetic biomarker of aging for lifespan and healthspan." Aging, 10(4), 573-591.
Introduces PhenoAge, an epigenetic clock that predicts all-cause mortality and healthspan better than chronological age, and can be used to measure the effectiveness of anti-aging interventions.
Fahy GM, Brooke RT, Watson JP, et al. (2019). "Reversal of epigenetic aging and immunosenescent trends in humans." Aging Cell, 18(6), e13028.
Small clinical trial demonstrating that a cocktail of growth hormone, DHEA, and metformin reversed epigenetic age by an average of 2.5 years over one year of treatment.
DIETARY INTERVENTION
Caloric Restriction & Longevity
Mattison JA, Colman RJ, Beasley TM, et al. (2017). "Caloric restriction improves health and survival of rhesus monkeys." Nature Communications, 8, 14063.
Long-term study showing that caloric restriction in primates delayed the onset of age-related diseases, improved healthspan markers, and showed trends toward increased lifespan.
Fontana L, Partridge L. (2015). "Promoting health and longevity through diet: from model organisms to humans." Cell, 161(1), 106-118.
Reviews evidence from multiple species showing caloric restriction without malnutrition extends lifespan and delays aging, examining translational potential for humans.
Kraus WE, Bhapkar M, Huffman KM, et al. (2019). "2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial." Lancet Diabetes & Endocrinology, 7(9), 673-683.
CALERIE trial showing that 2 years of 25% caloric restriction in humans improved multiple cardiometabolic risk factors including insulin sensitivity, blood pressure, and inflammation markers.
PHYSICAL ACTIVITY
Exercise & Healthy Aging
Booth FW, Roberts CK, Laye MJ. (2012). "Lack of exercise is a major cause of chronic diseases." Comprehensive Physiology, 2(2), 1143-1211.
Comprehensive review demonstrating that physical inactivity is a primary cause of most chronic diseases and that regular exercise is one of the most effective interventions for healthy aging.
Pedersen BK, Saltin B. (2015). "Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases." Scandinavian Journal of Medicine & Science in Sports, 25 Suppl 3, 1-72.
Evidence-based review showing exercise has therapeutic effects comparable to pharmaceutical interventions for numerous age-related conditions including cardiovascular disease, diabetes, and cognitive decline.
Robinson MM, Dasari S, Konopka AR, et al. (2017). "Enhanced Protein Translation Underlies Improved Metabolic and Physical Adaptations to Different Exercise Training Modes in Young and Old Humans." Cell Metabolism, 25(3), 581-592.
Shows that exercise improves mitochondrial function and cellular protein synthesis in both young and older adults, with high-intensity interval training particularly effective at reversing age-related cellular decline.
DIETARY PATTERNS
Mediterranean Diet & Longevity
Estruch R, Ros E, Salas-Salvadó J, et al. (2018). "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts." New England Journal of Medicine, 378(25), e34.
PREDIMED trial showing Mediterranean diet supplemented with olive oil or nuts reduced cardiovascular events by 30%, demonstrating significant health benefits of this dietary pattern.
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. (2003). "Adherence to a Mediterranean diet and survival in a Greek population." New England Journal of Medicine, 348(26), 2599-2608.
Demonstrates that greater adherence to Mediterranean dietary patterns is associated with significant reduction in total mortality and mortality from coronary heart disease and cancer.
PSYCHOSOCIAL FACTORS
Social Connection & Longevity
Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. (2015). "Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Review." Perspectives on Psychological Science, 10(2), 227-237.
Meta-analysis showing social isolation and loneliness carry mortality risk comparable to smoking 15 cigarettes per day, exceeding risks from obesity and physical inactivity.
Berkman LF, Glass T, Brissette I, Seeman TE. (2000). "From social integration to health: Durkheim in the new millennium." Social Science & Medicine, 51(6), 843-857.
Reviews mechanisms through which social relationships influence health outcomes, including effects on health behaviors, psychological states, and physiological pathways affecting longevity.